Related Experiment Video
Updated: Jun 22, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
PDCD4 inhibits the malignant phenotype of ovarian cancer cells
Zeng-Tao Wei1, Xia Zhang, Xiao-Yan Wang
1Institute of Immunology, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Jinan, China.
Abstract:
Programmed cell death 4 (PDCD4) is a newly identified tumor suppressor that can inhibit activator protein (AP)-1 activation and protein translation. Our previous studies indicate that lost or reduced PDCD4 expression is associated with the progression of ovarian carcinoma. However, direct evidence that PDCD4 inhibits malignant phenotype of human cancer cells is limited. In the present study, we found that PDCD4 expression in ovarian cancer cell lines (SKOV3, 3AO, and CAOV3) inhibited significantly their proliferation and cell cycle progression, and induced apoptosis. More importantly, up-regulation of PDCD4 expression decreased the colony-forming capacity of ovarian cancer cells in vitro and tumorigenic capacity in mice. These results demonstrate that PDCD4 can suppress the malignant phenotype of ovarian cancer cells, and may represent a novel therapeutic target for the treatment of ovarian cancer.
Insights
Programmed cell death 4 (PDCD4) suppresses ovarian cancer progression by inhibiting cell proliferation and inducing apoptosis. Upregulating PDCD4 reduces tumor growth, suggesting it as a potential therapeutic target for ovarian carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Programmed cell death 4 (PDCD4) is a tumor suppressor involved in inhibiting activator protein (AP)-1 activation and protein translation.
- Reduced PDCD4 expression is linked to ovarian carcinoma progression, but direct evidence of its tumor-suppressive role in human cancer cells is limited.
Purpose of the Study:
- To investigate the direct impact of PDCD4 on the malignant phenotype of human ovarian cancer cells.
- To evaluate PDCD4's potential as a therapeutic target for ovarian cancer.
Main Methods:
- Assessing PDCD4 expression in ovarian cancer cell lines (SKOV3, 3AO, CAOV3).
- Analyzing the effects of PDCD4 modulation on cell proliferation, cell cycle progression, and apoptosis.
- Evaluating the impact of PDCD4 on colony-forming capacity in vitro and tumorigenic capacity in vivo (mice).
Main Results:
- PDCD4 expression significantly inhibited proliferation and cell cycle progression in ovarian cancer cell lines.
- Increased PDCD4 expression induced apoptosis in these cells.
- Upregulation of PDCD4 reduced colony formation in vitro and tumor growth in mice.
Conclusions:
- PDCD4 effectively suppresses the malignant phenotype of ovarian cancer cells.
- PDCD4 represents a promising novel therapeutic target for ovarian cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation

